Hims & Hers Health Inc. is a telehealth company that offers personalized health and wellness solutions. The company was founded in 2017 with the goal of providing accessible and affordable healthcare services to individuals across various demographics. Hims & Hers operates through a digital platform that allows users to connect with licensed healthcare professionals and receive medical advice, prescriptions, and treatments for a wide range of conditions.
The company focuses on several key areas, including men's and women's health, sexual health, skincare, hair loss, and mental health. They offer a range of products, including prescription medications, over-the-counter treatments, supplements, and personal care items. Hims & Hers aims to destigmatize conversations around sensitive health topics by providing a discreet and convenient online platform for individuals to seek professional guidance and access necessary treatments.
Hims & Hers went public on the New York Stock Exchange (NYSE) on January 21, 2021, through a merger with Oaktree Acquisition Corp, a special purpose acquisition company (SPAC). The merger enabled Hims & Hers to become a publicly traded company under the ticker symbol "HIMS." Going public allowed the company to raise additional capital and increase its visibility in the market, supporting its growth and expansion plans.
As a telehealth company, Hims & Hers leverages technology to bridge the gap between patients and healthcare providers, making it easier for individuals to receive quality care from the comfort of their own homes. The platform offers a user-friendly interface that facilitates virtual consultations, prescription delivery, and ongoing monitoring of patients' health. This digital approach allows for increased accessibility and convenience, particularly for individuals with busy schedules or limited access to traditional healthcare services.